![]() |
|
|
Vol. 304, Issue 1, 30-36, January 2003
1 or
2 Subunit of GABAA
Receptors Reduces Actions of Alcohol and Other Drugs
Waggoner Center for Alcohol and Addiction Research and Section of Neurobiology, University of Texas at Austin, Austin, Texas (Y.A.B., S.J., H.A., D.W., R.A.H.); and Neuroscience Research Center, Merck Sharp and Dohme Research Laboratories, Harlow, Essex, United Kingdom (T.R., P.-J.W.).
| |
Abstract |
|---|
|
|
|---|
Enhancement of the activation of GABAA receptors is a
common feature of many sedative and hypnotic drugs, and it is probable that the GABAA receptor complex is a molecular target for
these drugs in the mammalian central nervous system. We set out to
elucidate the role of the two predominant (
1 and
2) subunits of GABAA receptor in sedative
drug action by studying mice lacking these two subunits. Both
1 (
/
) and
2 (
/
) null mutant mice
showed markedly decreased sleep time induced by nonselective
benzodiazepine, flurazepam, and GABAA agonist,
4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol. The sleep time induced by the
-selective drug etomidate was
decreased only in
2 (
/
) knockout mice. In contrast,
1 (
/
) mice were more resistant to the
1-selective drug zolpidem than
2 (
/
) or wild-type animals. Knockout mice of both strains were similar to
wild-type mice in their responses to pentobarbital. The duration of
loss of the righting reflex produced by ethanol was decreased in male
mice for both null alleles compared with wild-type mice, but there were
no differences in ethanol-induced sleep time in mutant females.
Deletion of either the
1 or
2 subunits
reduced the muscimol-stimulated 36Cl
influx
in cortical microsacs suggesting that these mutant mice have reduced
number of functional brain GABAA receptors. Our results show that removal of either
1 or
2
subunits of GABAA receptors produce strong and selective
decreases in hypnotic effects of different drugs. Overall, these data
confirm the crucial role of the GABAA receptor in
mechanisms mediating sedative/hypnotic effects.
| |
Introduction |
|---|
|
|
|---|
GABA,
acting via GABAA receptors, is the brain's major
inhibitory neurotransmitter system in the central nervous system.
Because the ability to enhance the ion channel activation of
GABAA receptors is a common feature of many
sedative and hypnotic drugs, it is probable that the action on the
GABAA receptor complex is a molecular target for
these drugs in the mammalian central nervous system (Charney et al.,
2001
). Nevertheless, many of these drugs, including ethanol and
pentobarbital, may have multiple sites of action and the importance of
specific GABAA receptors in drug action is not clearly defined.
The GABAA receptor has a pentameric structure,
which is formed by the coassembly of subunit polypeptides that exist in
a large multigene family (McKernan and Whiting, 1996
; Barnard et al., 1998
). There are at least 16 different members of the
GABAA receptor gene family, including 6
, 3
,
3
,
,
,
, and
subunits (Whiting et al., 1999
). The
largest population of GABAA receptors in the rat
brain has a subunit composition of
1
2
2, whereas
together
2
3
2 and
3
2/
3
constitute the next most prevalent subtypes (McKernan and Whiting,
1996
). GABA affinity is mainly governed by
subunits (Smith et al.,
2001
), but affinity and efficacy at the benzodiazepine site are
influenced by both
and
subunits (McKernan et al., 1995
; Buhr et
al., 1996
; Wingrove et al., 1997
) but not
subunits (Hadingham et
al., 1993
). The benzodiazepine site occurs at the interface of an
and a
subunit, with residues in both influencing modulation (Smith
and Olsen, 1995
). The presence of
2 confers
the classical benzodiazepine pharmacology to
GABAA receptors (Pritchett et al., 1989
). In
contrast,
subunits control loreclezole and etomidate sensitivity
(Stevenson et al., 1995
). Mouse strains lacking individual
GABAA receptor subunits provide insight regarding
the role of GABA receptors. Mice lacking the
2
subunit die shortly after birth (Gunther et al., 1995
), whereas mice
deficient the
2L (long splice variant) subunit
are viable and show small increases in sleep time responses to
midazolam and zolpidem, but responses to nonbenzodiazepine agents such
as ethanol, etomidate, and pentobarbital are unchanged (Quinlan et al.,
2000
).
3 null mice (
/
) did not show any
changes in sleep times after administration of pentobarbital or
ethanol, but they were more resistant to etomidate and midazolam
(Quinlan et al., 1998
). Mice lacking the
6
subunit of the GABAA receptor, which is expressed
exclusively in cerebellar granule cells, have no major phenotypic
abnormalities (Jones et al., 1997
). Mice deficient the
subunit are
also viable but show attenuated sensitivity to neuroactive steroids and
epileptic seizures (Mihalek et al., 1999
). Thus, deletion of some of
the less abundant GABAA receptor subunits reduces
the action of some sedative drugs, but they do not provide evidence for
a major role for GABA receptors in actions of many sedatives. It is
important to note, however, that the only predominant
GABAA subunit that has been deleted is the
2 and this proved lethal.
Recently, mice lacking the most predominant GABAA
receptor subunits,
1 and
2, were successfully generated (Sur et al.,
2001
; Kralic et al., 2002
). Although the mice lack approximately 60% of the total number of brain GABAA receptors,
adult
1 (
/
) and
2
(
/
) mice do not display major phenotypic abnormalities or spontaneous seizures.
1 (
/
) mice showed
overexpression of the
2 and
3 subunit but lack approximately 40% of the
GABAA receptors despite this apparent
compensation. In contrast,
2 (
/
) mice displayed an equal reduction in all six
subunits and a loss of
GABAA receptors of about 50% (Sur et al., 2001
).
In this study, we asked how this substantial decrease of
benzodiazepine receptors and reduction of expression of different GABA
receptor subtypes might affect receptor function by measuring agonist
stimulated 36Cl
uptake in
brain tissue from these mutant mice. For the behavioral studies, we
used the loss of righting reflex and tested a
GABAA agonist,
4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP), a
nonselective benzodiazepine, flurazepam, and
1-selective drug, zolpidem, a
-selective
drug, etomidate, and two drugs with activities on several channels in
addition to GABAA, ethanol and pentobarbital.
| |
Materials and Methods |
|---|
|
|
|---|
Animals.
Null
1 (
/
) and
2 (
/
) allele mice were created using
homologous recombination and genotyped as previously described in Sur
et al. (2001)
. Homozygotes of the F2 generation were interbred avoiding
any brother-sister mating, and homozygous colonies of
1 (
/
),
2 (
/
)
and wild-type (+/+) mice were established. In this study, the mice from
the F6 to F7 generations of this interbreeding have been used.
Loss of Righting Reflex.
Sensitivity to ethanol (Aaper
Alcohol and Chemical Co., Shelbyville, KT; 3.4, 3.6, and 3.8 g/kg,
i.p.), flurazepam (Sigma-Aldrich, St. Louis, MO; 225.0 mg/kg, i.p.),
zolpidem tartrate (gift from Dr. J. S. Vedo; Pharmacia, Skokie,
IL; 60.0 mg/kg, i.p.), pentobarbital (Sigma/RBI, Natick, MA; 50.0 mg/kg, i.p.), etomidate (40.0 mg/kg, i.p.), and THIP (Sigma/RBI; 55.0 mg/kg, s.c.) was determined using the standard sleep time assay
(Kakihana et al., 1966
). Ethanol was diluted in 0.9% saline (20.0%
w/v) and administered in doses adjusted by injected volumes.
Flurazepam, zolpidem, and etomidate were dissolved in 3 to 4 drops of
Tween 80 (Sigma-Aldrich) before saline was added and injected at 0.01 ml/g b.wt. Pentobarbital was dissolved in 0.9% saline and injected at
0.01 ml/g b.wt. THIP was dissolved in 0.9% saline and injected at
0.005 ml/g b.wt.
36Cl
Uptake.
The procedure was
carried out according to Allan and Harris (1986)
. Animals were killed
by decapitation, and their brains were removed and placed in ice-cold
buffer (145 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 10 mM glucose, 1 mM
CaCl2, and 10 mM HEPES; adjusted to pH 7.5 with
Tris base). The brain was homogenized by hand (10-12 strokes) using a
glass-Teflon homogenizer (size C; Thomas Scientific, Swedesboro, NJ) in
5 ml of ice-cold assay buffer. The homogenate was centrifuged at
900g for 15 min. The supernatant was decanted, and the
pellet was washed with 10 ml of assay buffer and centrifuged at
900g for 15 min. The final pellet was suspended in ice-cold assay buffer. Aliquots (0.2 ml) of membrane vesicles (0.6-0.8 mg of
protein) were incubated for 5 min in a shaking water bath at 30°C.
After this incubation, uptake was initiated by the addition of 0.2 ml
of 36Cl
(2 mCi/ml assay
buffer) (specific activity 12.8 mCi/g of Cl; obtained from ICN, Irvine,
CA) containing 1 to 20 µM muscimol (final concentration). Three
seconds after the addition
36Cl
influx was
terminated by the addition of 4 ml of ice-cold assay buffer containing
100 µM picrotoxin, and rapid filtration under vacuum (10 mm
Hg) onto a Whatman GF/C glass microfiber filter (Whatman, Clifton, NJ)
using a Hoeffer manifold (Hoefer Scientific, San Francisco, CA) was
performed. The filters were washed with an 8-ml assay buffer containing
100 µM picotoxin with the manifold towers removed. The amount of
radioactivity on the filters was determined by liquid scintillation
spectrometry. The amount of 36Cl
bound to the filter
in the absence of membranes (no tissue blank) was subtracted from all
values. Muscimol-dependent influx was defined as the amount of
36Cl
taken up while
muscimol was present minus the amount of
36Cl
taken up in the
absence of muscimol. The apparent potency (EC50) and apparent efficacy (Emax) of
muscimol was determined by the construction of a dose-response curve
using five concentrations of the drug. The modulation of
muscimol-stimulated 36Cl
uptake by ethanol (25 mM), pentobarbital (25 µM), and flunitrazepam (0.1 µM) was determined by comparing
36Cl
uptake in solutions
of each different type of drug containing 36Cl
and 0.65 µM of
muscimol for wild-type (+/+) cortex and
36Cl
and 1.0 µM of
muscimol for cortex from
1 (
/
) and
2 (
/
) null mutant mice with solutions
containing only 36Cl
and
the corresponding muscimol concentrations for each genotype. These
concentrations of muscimol induced a similar stimulation of uptake in
all three genotypes. Net uptake was defined as the amount of
36Cl
uptake in the
presence of muscimol, corresponding to each genotype concentration,
plus the drug tested minus the
36Cl
uptake in the
presence of muscimol alone.
Data Analysis.
The results are expressed as mean ± S.E.M. The data are reported in minutes for sleep time. For
36Cl
uptake studies,
Emax was determined from the
dose-response data as the change in
36Cl
flux at the
maximally effective concentration, and EC50 was
determined by linearly transforming the data (sigmoid curve analysis)
using the GraphPad computer program (GraphPad Software, Inc., San
Diego, CA). Statistical analysis of parameters was made using the
Student's t test with Dunnet's correction for multiple
comparisons (Winer, 1971
) or by two-way ANOVA whenever appropriate. For
all statistical comparisons, p
0.05 was considered significant.
| |
Results |
|---|
|
|
|---|
The duration of loss of righting reflex (sleep time) produced by
ethanol was decreased in both null allele males compared with wild-type
mice (P < 0.0001, dependence on genotype;
P < 0.0001, dependence on dose, two-way ANOVA) (Fig.
1a). The residual response to ethanol was
similar in
1 and
2
null mutant males. There were no differences in ethanol-induced sleep
time in mutant females (Fig. 1b), however. Null allele mice of both
strains did not differ from wild-type mice in their responses to
pentobarbital (Fig. 1, c and d).
|
Analysis of flurazepam and THIP-induced loss of righting reflex
revealed that
1 (
/
) and
2 (
/
) null mutant mice showed markedly
decreased sleep time in comparison with wild-type mice (Fig.
2, a and b). Both sexes of mutant mice
showed similar changes in response.
|
The duration of sleep time induced by etomidate was significantly
decreased only in
2 (
/
) males (Fig.
3a) and females (Fig. 3b).
1 (
/
) mice of both sexes did not differ
from wild-type animals in their sensitivity to etomidate. In contrast,
1 (
/
) mice were more resistant to zolpidem
(60 mg/kg) in comparison with wild-type animals (Fig. 3, c and d).
There was no difference in resistance to zolpidem-induced sleep time
between
2 (
/
) and
1 (
/
) females (Fig. 3d). On the other
hand,
2 (
/
) males showed resistance
intermediate between
1 (
/
) null mutant and wild-type males (Fig. 3c).
|
To determine whether the deletion of
1 or
2 subunits changed the
GABAA receptor function, muscimol-stimulated
36Cl
influx was measured
in cortical microsacs. Deletion of either the
1 or
2 subunits
reduced the response to muscimol (Fig.
4a). The muscimol
EC50 was approximately 2-fold higher in both
mutant strains than in wild-type mice. The deletion of the
2 subunit significantly increased the slope of
muscimol response. The maximal effect of muscimol was approximately
25% higher in membranes from wild-type animals compared with the null
mutants (Table 1).
|
|
Flunitrazepam enhanced muscimol-stimulated
36Cl
uptake equally in
microsacs from wild-type and
2 null mutant
mice. Potentiation of muscimol response by flunitrazepam, however, was
significantly higher in membranes from
1
(
/
) mice than from wild-type mice (Fig. 4b). In contrast, there
were no differences in potentiation of muscimol response by
pentobarbital in the three genotypes (Fig. 4c). Ethanol potentiation of
muscimol-stimulated 36Cl
influx was significantly decreased in
2
(
/
) mice (Fig. 4d). There were no differences in these ethanol
effects between males and females. Ethanol potentiated
muscimol-stimulated 36Cl
influx by 1.70 ± 0.16- and 1.69 ± 0.14-fold in wild-type
mice, 1.62 ± 0.22- and 1.75 ± 0.23-fold in
1 (
/
) knockout mice, and 1.37 ± 0.07- and 1.15 ± 0.16-fold in
2 null
mutant mice (males and females, respectively).
| |
Discussion |
|---|
|
|
|---|
Taken together, these results show that deletion of either the
1 or
2 subunits of
GABAA receptor reduced the behavioral effects of
a wide variety of sedative hypnotic drugs (summarized in Table
2) and indicate that these mutant mice
have a reduced number of functional brain GABAA
receptors.
|
The reductions in sleep time produced by the mutations are generally
consistent with biochemical studies of brain and recombinant receptors,
indicating that THIP and flurazepam affect most
GABAA receptors and thus show similar effects of
deletion of either the
1 or
2 subunit. For etomidate, subtypes of the
-subunit influence the potency with which etomidate potentiates
GABA-evoked currents and the
isoform is a crucial determinant of
the GABA-mimetic activity of this compound (Hill-Venning et al., 1997
).
Concerning the effects of etomidate on recombinant
GABAA receptors composed of
1,
2S, and either
1,
2, or
3 subunits, Sanna et al. (1997)
showed that
the order of potency after application of this drug was
3 >
2 >
1. In accordance with these findings, the loss of righting reflex produced by etomidate was reduced only in the
2 mutants not in the
1 knockouts.
Zolpidem has a higher affinity for GABAA
receptors containing
1 subunits than for other
receptors (Pritchett et al., 1989
; Sieghart, 1995
), and sleep time
produced by this drug was markedly decreased in
1 null mutant mice. Nevertheless,
2 knockout mice also showed a significant
decrease in zolpidem-induced sleep time. This is perhaps surprising in
view of the findings that there was a complete loss of high-affinity
binding sites for zolpidem in
1 (
/
) mice,
whereas high-affinity zolpidem binding sites still accounted for 49%
of total [3H]flumazenil sites in
2 (
/
) brains (Sur et al., 2001
). It should be noted, however, that at the high doses used to produce loss of
righting reflex, it is likely that zolpidem is not completely selective
for
1-containing receptors.
In view of the clear changes in action of these GABAergic drugs, it was
surprising that pentobarbital sleep time was not altered in the mutant
mice, but this is consistent with the robust potentiation by
pentobarbital of the GABA current in Purkinje cells isolated from these
mutant mice (Sur et al., 2001
). In addition, deletion of another
subunit,
3, also failed to change
pentobarbital sleep time (Quinlan et al., 1998
). Pentobarbital has
effects on a number of other ion channels (Wartenberg et al., 2001
;
Yamakura et al., 2001
; Bachmann et al., 2002
), and it is possible that these targets are more important for pentobarbital-induced loss of
righting reflex than the GABAA receptor.
Reduction of alcohol sleep time by deletion of either the
1 or
2 subunit is
consistent with the idea that ethanol enhances GABAA receptor function and thereby produces some
of its behavioral effects (Harris, 1999
). The effect of the null
mutations was only seen in male mice, however, suggesting that females
may employ additional mechanisms for production of ethanol effects or
that the GABAA receptor action of ethanol is less
important in female mice. There is evidence for gender differences in
alcohol sleep time and genetic influences upon that behavior (DeFries
et al., 1989
). In addition, neurosteroids derived from progesterone
have been implicated in alcohol actions, including loss of righting reflex (Morrow et al., 2001
). Thus, actions of ethanol such as loss of
righting reflex likely involve multiple targets, including the
GABAA receptor.
Results from GABA receptor function measured in cortical membranes by
chloride flux are generally consistent with previous biochemical and
current behavioral studies of these mice. In particular, both knockout
strains showed decreased maximum stimulation of muscimol-stimulated
36Cl
uptake. Sur at al.
(2001)
showed that both the
1 (
/
) and
2 (
/
) mice demonstrated a large (50-70%)
widespread loss of GABAA receptors measured by
[35S]t-butylbicyclophosphorothionate
and [3H]muscimol binding and of benzodiazepine
binding sites measured by [3H]flumazenil
binding. Nevertheless, the 25% decrease in chloride flux
(Emax) that we observed suggests that
mutant mice compensate for loss of receptor subunits by either more
efficient trafficking of receptors to the membrane surface or greater
function of remaining receptors. In addition to the decrease in
Emax, the mutant mice also showed an
increased muscimol EC50, likely a consequence of subunit substitution in the remaining receptors. The potency of muscimol varies with the type of
subunit incorporated into the GABAA receptor complex in the order
6 >
5 =
2 >
1 >
3 (Ebert et al., 1997
) and substitution of
3 for
1 as a possible
explanation for the decreased muscimol EC50 in
mutant mice. At first glance, the ability to potentiate the
36Cl
uptake by several
different sedatives does not appear consistent with behavioral effects
of these drugs. For example, potentiation of muscimol action by
flunitrazepam was not changed in
2 knockout mice and was increased in
1 null mutant mice,
despite decreased sleep times in both mutants. It should be noted,
however, that we are measuring flunitrazepam effects on the remaining
GABAA receptors; thus, these potentiation values
do not reflect the loss of GABA receptors. It appears that the reason
for the decrease in behavioral actions of flurazepam is the decrease in
number of GABAA receptors, not a change in the
properties of the remaining receptors. On the other hand, the increase
in flunitrazepam potentiation of muscimol action in
1 null mutant mice could reflect
overexpression of
2 and
3 subunits in these mice (Sur et al., 2001
).
It is known that the benzodiazepine potentiation of GABA action is
greater at
3
3
2
subunits than at
1 or
5 containing receptors (Smith at al., 2001
).
In the case of ethanol, however, there is evidence for decreased
sensitivity of the remaining receptors, at least in the
2 null mutants.
The majority of gene-targeted mice are developed on a mixed genetic
background of inbred mouse strains C57BL/6J and strain 129, and it is
useful to compare the responses of wild-type and null allele mice to
the pattern of responses found in the parental mouse strains used. In
the present study, genes linked to the
1
(
/
) and
2 (
/
) mutations would be
derived from strain 129/SvEv, whereas genes linked to the wild-type
1 and
2 genes would
stem from C57BL/6J. Two recent articles (Simpson et al., 1997
;
Threadgill et al., 1997
) have shown that there is substantial genetic
variation among substrains of 129 inbred strain. There are no available data about effects of sedative drugs in the 129/SvEv substrain. Homanics et al. (1999)
found that 129/SvJ and C57BL/6J inbred strains
have similar hypnotic responses to ethanol and pentobarbital. 129/SvJ
mice, however, are markedly less sensitive to the hypnotic effects of
midazolam, zolpidem, and propofol (sleep times 30, 65, and 52% of the
C57BL/6J values, respectively), whereas 129/SvJ are significantly less
resistant to etomidate (30% greater sleep time than C57BL/6J). Because
our data show a decrease of ethanol-induced sleep in
1 (
/
) and
2
(
/
) males and of etomidate-induced sleep only in
2 (
/
) mice, these effects are most likely
the result of mutations and not of flanking genes from the 129/SvEv strain.
Another concern with studies of null mutant mice is compensation
(Crawley, 1996
; Gerlai, 2001
). It is likely that some compensatory changes occur in the brain to allow near normal brain function without
1 or
2 subunits. Our
data showing only a 25% decrease in the maximal chloride flux through
GABAa receptors in the face of a larger loss of
receptor density suggests one type of compensation. Interestingly, very
similar results were recently obtained from independently generated
1 knockout mice (Kralic et al., 2002
).
In conclusion, these data show that removal of either
1 or
2 subunits of
GABAA receptors produce strong and specific
decreases effects of different drugs. Overall, these data confirm the
crucial role of the GABAA receptor in mechanisms
mediating sedative/hypnotic effects.
| |
Acknowledgments |
|---|
We thank Dr. Gregg Homanics for helpful discussions and comments on the experiments.
| |
Footnotes |
|---|
Accepted for publication September 11, 2002.
Received for publication August 8, 2002.
This work was supported by funds from the Texas Commission on Alcohol and Drug Abuse and National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism Grants AA06399 and AA13520.
DOI: 10.1124/jpet.102.042960
Address correspondence to: Dr. Yuri A. Blednov, The University of Texas at Austin Waggoner Center for Alcohol and Addiction Research, 1 University Station, A4800 2500 Speedway MBB 1.124, Austin, TX 78712-0159. E-mail: yablednov{at}mail.utexas.edu
| |
Abbreviations |
|---|
THIP, 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol; ANOVA, analysis of variance.
| |
References |
|---|
|
|
|---|
-Aminobutyric acid and alcohol actions: neurochemical studies of long sleep and short sleep mice.
Life Sci
39:
2005-2015[CrossRef][Medline].
-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.
Pharmacol Rev
50:
291-313
1
2
2
-aminobutyric acidA receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
Mol Pharmacol
49:
1080-1084[Abstract].
subunit in determining the pharmacology of human
-aminobutyric acid type A receptors.
Mol Pharmacol
44:
1211-1218[Abstract].
-aminobutyric acid type A receptor.
Br J Pharmacol
120:
749-756[CrossRef][Medline].
6 subunit gene inactivation inhibits
subunit expression.
J Neurosci
17:
1350-1362
1 subunit knockout mice.
J Pharmacol Exp Ther
302:
1037-1045
-subunit present.
J Recept Signal Transduct Res
15:
173-183[Medline].
-aminobutyrate type A receptor
subunit knockout mice.
Proc Natl Acad Sci USA
96:
12905-12910
2 subunit of the GABAA receptor are more sensitive to benzodiazepines.
Pharmacol Biochem Behav
66:
371-374[CrossRef][Medline].
3 subunit of the
-aminobutyric acid type A receptor.
Anesthesiology
88:
775-780[CrossRef][Medline].
-aminobutyric type A receptors expressed in Xenopus laevis oocytes.
Mol Pharmacol
51:
484-490
-aminobutyric acid A receptor subtypes.
Am Soc Pharmacol Exp Ther
47:
181-234.
subunit on allosteric modulation of ion channel function in stably expressed human recombinant
-aminobutyric acidA receptors determined using 36Cl ion flux.
Mol Pharmacol
59:
1108-1118
-Carboline
-aminobutyric acid A receptor inverse agonists modulate
-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site.
Mol Pharmacol
48:
965-969[Abstract].
subunit of the
-aminobutyric acid A receptor that determine ligand binding and modulation at the benzodiazepine site.
Mol Pharmacol
52:
874-881This article has been cited by other articles:
![]() |
J. Liang, I. Spigelman, and R. W. Olsen Tolerance to Sedative/Hypnotic Actions of GABAergic Drugs Correlates With Tolerance to Potentiation of Extrasynaptic Tonic Currents of Alcohol-Dependent Rats J Neurophysiol, July 1, 2009; 102(1): 224 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hu, I. V. Lund, M. C. Gravielle, D. H. Farb, A. R. Brooks-Kayal, and S. J. Russek Surface Expression of GABAA Receptors Is Transcriptionally Controlled by the Interplay of cAMP-response Element-binding Protein and Its Binding Partner Inducible cAMP Early Repressor J. Biol. Chem., April 4, 2008; 283(14): 9328 - 9340. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Akk, P. Li, B. D. Manion, A. S. Evers, and J. H. Steinbach Ethanol Modulates the Interaction of the Endogenous Neurosteroid Allopregnanolone with the {alpha}1beta2{gamma}2L GABAA Receptor Mol. Pharmacol., February 1, 2007; 71(2): 461 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Werner, Y. A. Blednov, O. J. Ariwodola, Y. Silberman, E. Logan, R. B. Berry, C. M. Borghese, D. B. Matthews, J. L. Weiner, N. L. Harrison, et al. Knockin Mice with Ethanol-Insensitive {alpha}1-Containing {gamma}-Aminobutyric Acid Type A Receptors Display Selective Alterations in Behavioral Responses to Ethanol J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 219 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Einat Modelling facets of mania - new directions related to the notion of endophenotypes J Psychopharmacol, September 1, 2006; 20(5): 714 - 722. [Abstract] [PDF] |
||||
![]() |
R. E. Petroski, J. E. Pomeroy, R. Das, H. Bowman, W. Yang, A. P. Chen, and A. C. Foster Indiplon Is a High-Affinity Positive Allosteric Modulator with Selectivity for {alpha}1 Subunit-Containing GABAA Receptors J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 369 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Platt, A. Duggan, R. D. Spealman, J. M. Cook, X. Li, W. Yin, and J. K. Rowlett Contribution of {alpha}1GABAA and {alpha}5GABAA Receptor Subtypes to the Discriminative Stimulus Effects of Ethanol in Squirrel Monkeys J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 658 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Maas Jr, S. K. Vogt, G. C. K. Chan, V. V. Pineda, D. R. Storm, and L. J. Muglia Calcium-Stimulated Adenylyl Cyclases Are Critical Modulators of Neuronal Ethanol Sensitivity J. Neurosci., April 20, 2005; 25(16): 4118 - 4126. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Wu, W. Poelchen, and W. R. Proctor Differential GABAB Receptor Modulation of Ethanol Effects on GABAA Synaptic Activity in Hippocampal CA1 Neurons J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1082 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Boehm II, L. Peden, R. A. Harris, and Y. A. Blednov Deletion of the fyn-Kinase Gene Alters Sensitivity to GABAergic Drugs: Dependence on {beta}2/{beta}3 GABAA Receptor Subunits J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1154 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Nie, P. Schweitzer, A. J. Roberts, S. G. Madamba, S. D. Moore, and G. R. Siggins Ethanol Augments GABAergic Transmission in the Central Amygdala via CRF1 Receptors Science, March 5, 2004; 303(5663): 1512 - 1514. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Sebe, E. D. Eggers, and A. J. Berger Differential Effects of Ethanol on GABAA and Glycine Receptor-Mediated Synaptic Currents in Brain Stem Motoneurons J Neurophysiol, August 1, 2003; 90(2): 870 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Blednov, D. Walker, H. Alva, K. Creech, G. Findlay, and R. A. Harris GABAA Receptor {alpha}1 and {beta}2 Subunit Null Mutant Mice: Behavioral Responses to Ethanol J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 854 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Kralic, M. Wheeler, K. Renzi, C. Ferguson, T. K. O'Buckley, A. C. Grobin, A. L. Morrow, and G. E. Homanics Deletion of GABAA Receptor alpha 1 Subunit-containing Receptors Alters Responses to Ethanol and Other Anesthetics J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 600 - 607. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||